72.55
Overview
News
Price History
Option Chain
Financials
Why MET Down?
Discussions
Forecast
Dividend History
Metlife Inc stock is traded at $72.55, with a volume of 2.69M.
It is up +1.19% in the last 24 hours and down -11.70% over the past month.
MetLife is one of the largest life insurers in the us by assets and provides a variety of insurance and financial-services products. It is organized into five segments: us, Asia, Latin America, Europe/Middle East/Africa, and MetLife Holdings. The us business contributes around 50% of earnings and is broken into the group benefits segment and the retirement solutions segment. The Asia segment contributes around 22% of earnings and is mainly composed of the Japan business, with increasing contributions from India, China, and Bangladesh. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of earnings. The EMEA and MetLife Holdings segments contribute around 4% and 11% of earnings, respectively.
See More
Previous Close:
$71.70
Open:
$72.3
24h Volume:
2.69M
Relative Volume:
0.72
Market Cap:
$49.70B
Revenue:
$70.02B
Net Income/Loss:
$4.43B
P/E Ratio:
12.16
EPS:
5.9653
Net Cash Flow:
$14.60B
1W Performance:
+2.03%
1M Performance:
-11.70%
6M Performance:
-15.33%
1Y Performance:
+5.27%
Metlife Inc Stock (MET) Company Profile
Name
Metlife Inc
Sector
Industry
Phone
212-578-5500
Address
200 PARK AVENUE, NEW YORK, NY
Compare MET with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
MET
Metlife Inc
|
72.55 | 49.70B | 70.02B | 4.43B | 14.60B | 5.9653 |
![]()
AFL
Aflac Inc
|
107.44 | 59.23B | 19.13B | 5.44B | 2.71B | 9.60 |
![]()
MFC
Manulife Financial Corp
|
28.61 | 49.42B | 33.37B | 4.10B | 19.33B | 2.0661 |
![]()
PRU
Prudential Financial Inc
|
99.47 | 35.95B | 70.65B | 2.73B | 8.50B | 7.4655 |
![]()
PUK
Prudential Plc Adr
|
20.74 | 26.10B | 8.14B | 2.29B | 3.51B | 1.68 |
Metlife Inc Stock (MET) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jan-23-25 | Initiated | BMO Capital Markets | Market Perform |
Oct-09-24 | Initiated | TD Cowen | Buy |
Sep-05-24 | Initiated | Barclays | Overweight |
Jan-08-24 | Upgrade | Goldman | Neutral → Buy |
Nov-17-23 | Resumed | Barclays | Overweight |
Oct-05-23 | Initiated | Deutsche Bank | Hold |
Sep-14-23 | Upgrade | Jefferies | Hold → Buy |
Jan-09-23 | Downgrade | Goldman | Buy → Neutral |
Dec-09-22 | Downgrade | Jefferies | Buy → Hold |
Sep-22-22 | Initiated | Raymond James | Mkt Perform |
Jun-23-22 | Upgrade | Wolfe Research | Peer Perform → Outperform |
May-24-22 | Initiated | Citigroup | Buy |
Jan-26-22 | Initiated | Jefferies | Buy |
Jan-21-22 | Initiated | Wolfe Research | Peer Perform |
Jan-12-22 | Reiterated | UBS | Buy |
Jan-05-22 | Upgrade | Evercore ISI | In-line → Outperform |
Dec-03-21 | Initiated | Goldman | Buy |
Apr-21-21 | Initiated | UBS | Buy |
Jan-06-21 | Upgrade | Piper Sandler | Neutral → Overweight |
Dec-08-20 | Upgrade | Citigroup | Neutral → Buy |
Dec-04-20 | Initiated | Goldman | Neutral |
Nov-17-20 | Initiated | Barclays | Overweight |
Jun-01-20 | Resumed | BofA/Merrill | Buy |
Mar-16-20 | Upgrade | Citigroup | Sell → Neutral |
Jan-07-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
Jul-16-19 | Downgrade | Evercore ISI | Outperform → In-line |
Mar-19-19 | Downgrade | Sandler O'Neill | Buy → Hold |
Jan-16-19 | Upgrade | BofA/Merrill | Neutral → Buy |
Jan-02-19 | Upgrade | Sandler O'Neill | Hold → Buy |
Jun-04-18 | Downgrade | Goldman | Buy → Neutral |
Apr-25-18 | Initiated | Credit Suisse | Outperform |
Mar-26-18 | Upgrade | Atlantic Equities | Neutral → Overweight |
Jan-02-18 | Initiated | Deutsche Bank | Hold |
Nov-10-17 | Downgrade | Sandler O'Neill | Buy → Hold |
Nov-03-17 | Reiterated | RBC Capital Mkts | Outperform |
May-25-17 | Upgrade | FBR & Co. | Mkt Perform → Outperform |
Mar-06-17 | Downgrade | BofA/Merrill | Buy → Neutral |
Jan-26-17 | Initiated | Citigroup | Sell |
Dec-09-16 | Downgrade | Standpoint Research | Buy → Hold |
View All
Metlife Inc Stock (MET) Latest News
NFJ Investment Group LLC Reduces Stake in MetLife, Inc. (NYSE:MET) - MarketBeat
XTX Topco Ltd Sells 42,095 Shares of MetLife, Inc. (NYSE:MET) - MarketBeat
MetLife, Inc. (NYSE:MET) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Rockefeller Capital Management L.P. Purchases 15,114 Shares of MetLife, Inc. (NYSE:MET) - MarketBeat
Townsquare Capital LLC Acquires 13,712 Shares of MetLife, Inc. (NYSE:MET) - MarketBeat
Fmr LLC Buys 153,132 Shares of MetLife, Inc. (NYSE:MET) - MarketBeat
MetLife Will Get Trial in NY Corporate Franchise Tax Dispute - news.bloombergtax.com
Zacks Investment Management Sells 181,343 Shares of MetLife, Inc. (NYSE:MET) - MarketBeat
5,332 Shares in MetLife, Inc. (NYSE:MET) Purchased by Sagespring Wealth Partners LLC - MarketBeat
Bridgewater Associates LP Has $98.10 Million Stake in MetLife, Inc. (NYSE:MET) - MarketBeat
Dodge & Cox Sells 502,027 Shares of MetLife, Inc. (NYSE:MET) - MarketBeat
9,815 Shares in MetLife, Inc. (NYSE:MET) Bought by Canada Post Corp Registered Pension Plan - MarketBeat
Aware Super Pty Ltd as trustee of Aware Super Makes New $23.46 Million Investment in MetLife, Inc. (NYSE:MET) - MarketBeat
Sterling Capital Management LLC Trims Stake in MetLife, Inc. (NYSE:MET) - MarketBeat
Heritage Trust Co Invests $2.77 Million in MetLife, Inc. (NYSE:MET) - MarketBeat
Bank of Montreal Can Has $68.33 Million Stock Position in MetLife, Inc. (NYSE:MET) - MarketBeat
July 18th Options Now Available For MetLife (MET) - Nasdaq
MetLife Investment, Equitable, New York Life Agree to $700 Million Forward-Flow Facility for Octane - marketscreener.com
Fintech Powerhouse Octane Lands Massive $700M Deal with Insurance Leaders - Stock Titan
LSV Asset Management Sells 326,160 Shares of MetLife, Inc. (NYSE:MET) - MarketBeat
319,100 Shares in MetLife, Inc. (NYSE:MET) Bought by APG Asset Management N.V. - MarketBeat
Bank of Nova Scotia Reduces Stake in MetLife, Inc. (NYSE:MET) - MarketBeat
MetLife (NYSE:MET) Price Target Lowered to $95.00 at Keefe, Bruyette & Woods - MarketBeat
Invesco Ltd. Lowers Position in MetLife, Inc. (NYSE:MET) - MarketBeat
Bessemer Group Inc. Trims Position in MetLife, Inc. (NYSE:MET) - MarketBeat
Applied Finance Capital Management LLC Sells 7,163 Shares of MetLife, Inc. (NYSE:MET) - MarketBeat
Envestnet Asset Management Inc. Trims Stock Holdings in MetLife, Inc. (NYSE:MET) - MarketBeat
F M Investments LLC Grows Stock Position in MetLife, Inc. (NYSE:MET) - MarketBeat
MetLife (NYSE:MET) Sets New 1-Year LowWhat's Next? - MarketBeat
Barclays Adjusts MetLife (MET) Price Target Amidst Sector Uncertainty | MET Stock News - GuruFocus
MetLife, Inc. (NYSE:MET) Shares Bought by Russell Investments Group Ltd. - MarketBeat
DRW Securities LLC Increases Holdings in MetLife, Inc. (NYSE:MET) - MarketBeat
Legal & General Group Plc Sells 1,190,083 Shares of MetLife, Inc. (NYSE:MET) - MarketBeat
Resona Asset Management Co. Ltd. Invests $14 Million in MetLife, Inc. (NYSE:MET) - MarketBeat
MetLife, Inc. (NYSE:MET) Shares Acquired by Wells Fargo & Company MN - MarketBeat
Sit Investment Associates Inc. Makes New $5.15 Million Investment in MetLife, Inc. (NYSE:MET) - MarketBeat
MetLife, Inc. (NYSE:MET) Shares Bought by Unigestion Holding SA - MarketBeat
Aviva PLC Reduces Stock Holdings in MetLife, Inc. (NYSE:MET) - MarketBeat
Integrated Quantitative Investments LLC Buys Shares of 5,000 MetLife, Inc. (NYSE:MET) - MarketBeat
Wells Fargo Cuts Price Target on MetLife to $91 From $97, Keeps Overweight Rating - MarketScreener
Morgan Stanley Adjusts MetLife (MET) Price Target Amid Earnings Forecast Revisions | MET Stock News - GuruFocus
Barclays Cuts Price Target on MetLife to $88 From $95, Maintains Overweight Rating - MarketScreener
Wells Fargo Adjusts MetLife (MET) Price Target Amid Macroeconomi - GuruFocus
Jefferies Adjusts Price Target on MetLife to $96 From $103, Keeps Buy Rating - MarketScreener
Generative AI in Insurance Market Top Companies Study- MetLife, - openPR.com
Payden & Rygel Sells 168,500 Shares of MetLife, Inc. (NYSE:MET) - MarketBeat
10 Analysts Have This To Say About MetLife - Benzinga
BMO Capital Adjusts MetLife Price Target to $73 From $89, Maintains Market Perform Rating - MarketScreener
Morgan Stanley Adjusts Price Target on MetLife to $94 From $109, Keeps Overweight Rating - MarketScreener
MetLife, Inc. (NYSE:MET): Among the Best Insurance Stocks to Buy According to Hedge Funds - Insider Monkey
Keefe Bruyette & Woods Adjusts Price Target on MetLife to $95 From $98, Maintains Outperform Rating - MarketScreener
Metlife Inc Stock (MET) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):